Johnson & Johnson (NYSE:JNJ) reported earnings per share of $2.80, surpassing estimates and showing a revenue of$23.99 billion, exceeding expectations.The company has increased its 2025 revenue forecast, indicating a positive outlook based on its 15.7% increase in adjusted earnings per share compared to the previous year.JNJ announced plans to spin off its orthopedics business, marking a significant strategic move to focus more on its core operations.Johnson & Johnson (NYSE:JNJ), a leading healthcare congl ...